Prevention and Treatment of Patient Before, During, and After Covid-19 Infection

NCT05043324 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

INDIV

Sponsor class

Conditions

Covid19

Interventions

DRUG: AntiCov-220
DRUG: AntiCov-220 (placebo)

Sponsor

Nguyen Thi Trieu, MD